T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Total Debt Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual total debt in 2023 was 49.49 Million USD , down -16.41% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly total debt in 2024 Q2 was 19.22 Million USD , down -61.17% from previous quarter.
  • T2 Biosystems, Inc. reported annual total debt of 59.21 Million USD in 2022, up 3.62% from previous year.
  • T2 Biosystems, Inc. reported annual total debt of 57.14 Million USD in 2021, up 2.48% from previous year.
  • T2 Biosystems, Inc. reported quarterly total debt of 49.49 Million USD for 2024 Q1, down -0.0% from previous quarter.
  • T2 Biosystems, Inc. reported quarterly total debt of 49.49 Million USD for 2023 Q4, up 0.04% from previous quarter.

Annual Total Debt Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Total Debt of T2 Biosystems, Inc. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 49.49 Million USD -16.41%
2022 59.21 Million USD 3.62%
2021 57.14 Million USD 2.48%
2020 55.76 Million USD 24.55%
2019 44.77 Million USD 3.81%
2018 43.13 Million USD 1.06%
2017 42.68 Million USD 1.95%
2016 41.86 Million USD 30.68%
2015 32.03 Million USD 52.88%
2014 20.95 Million USD 314.29%
2013 5.05 Million USD -13.95%
2012 5.87 Million USD 0.0%

Peer Total Debt Comparison of T2 Biosystems, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 43.718%
Prenetics Global Limited 2.36 Million USD -1989.063%
Star Equity Holdings, Inc. 3.6 Million USD -1271.516%
CareDx, Inc 34.22 Million USD -44.642%
Exact Sciences Corporation 2.55 Billion USD 98.062%
Exagen Inc. 23.72 Million USD -108.667%
Inotiv, Inc. 417.64 Million USD 88.148%
Guardant Health, Inc. 1.35 Billion USD 96.344%
Biodesix, Inc. 60.69 Million USD 18.443%
BioNexus Gene Lab Corp. 133.39 Thousand USD -37006.338%
Precipio, Inc. 1.11 Million USD -4335.305%
iSpecimen Inc. 196.24 Thousand USD -25122.682%
Natera, Inc. 441.99 Million USD 88.801%
Aspira Women's Health Inc. 2.26 Million USD -2084.378%
Standard BioTools Inc. 98.21 Million USD 49.6%
23andMe Holding Co. 76.51 Million USD 35.309%
Castle Biosciences, Inc. 15.31 Million USD -223.305%
Personalis, Inc. 48.96 Million USD -1.095%
Aclaris Therapeutics, Inc. 426 Thousand USD -11519.249%
Applied DNA Sciences, Inc. 1.23 Million USD -3898.998%
OpGen, Inc. 13.04 Million USD -279.478%
Myriad Genetics, Inc. 145 Million USD 65.863%
ICON Public Limited Company 3.93 Billion USD 98.743%
NeoGenomics, Inc. 611.67 Million USD 91.908%
Star Equity Holdings, Inc. 3.6 Million USD -1271.516%
IDEXX Laboratories, Inc. 947.88 Million USD 94.778%
RadNet, Inc. 1.49 Billion USD 96.68%
MDxHealth SA 41.26 Million USD -19.952%
Psychemedics Corporation 2.29 Million USD -2053.96%
Illumina, Inc. 2.26 Billion USD 97.812%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 47.381%
DarioHealth Corp. 29.54 Million USD -67.557%
Fulgent Genetics, Inc. 14.9 Million USD -232.045%
Sera Prognostics, Inc. 1.85 Million USD -2564.047%
ENDRA Life Sciences Inc. 394.4 Thousand USD -12450.107%
OPKO Health, Inc. 326.56 Million USD 84.843%
Medpace Holdings, Inc. 142.12 Million USD 65.172%
Neogen Corporation 906.23 Million USD 94.538%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -5580.024%
Prenetics Global Limited 2.36 Million USD -1989.063%
Mainz Biomed B.V. 7.42 Million USD -567.019%
bioAffinity Technologies, Inc. 1.57 Million USD -3035.486%
Trinity Biotech plc 67.42 Million USD 26.59%
Neuronetics, Inc. 62.47 Million USD 20.77%
Sotera Health Company 2.32 Billion USD 97.873%
bioAffinity Technologies, Inc. 1.57 Million USD -3035.486%